Immunocore’s IMCgp100 To Participate In EMA’s Adaptive Pathway Pilot Programme
News
British biotechnology company Immunocore Limited recently announced its leading product, IMCgp100, has been accepted to participate in the European Medicines Agency’s ... Read more